Sterling Capital Management »

Aardvark Therapeutics shares owned by Sterling Capital Management

Quarter-by-quarter ownership of Aardvark Therapeutics (AARD) shares owned by Sterling Capital Management from 13F filings

Historical chart of Sterling Capital Management investment in Aardvark Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aardvark Therapeutics held by Sterling Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aardvark Therapeutics by Sterling Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.4k 182 13.29
2025-06-30 $1.0k 75 13.52

More positions owned by Sterling Capital Management

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Vanguard S&p 500 Etf Etf (VOO)
Apple (AAPL)
Charles Schwab Corporation (SCHW)
Analog Devices (ADI)
Amazon (AMZN)
Linde (LIN)
Ferguson (FERG)
Automatic Data Processing (ADP)
Home Depot (HD)
Ameriprise Financial (AMP)
Abbvie (ABBV)
Rockwell Automation (ROK)
Everest Re Group (EG)

View all positions for Sterling Capital Management

Top funds holding Aardvark Therapeutics

Decheng Capital
Citadel Advisors
Laurion Capital Management
Vanguard Group
Adage Capital Partners GP
Millennium Management
BlackRock
Silverarc Capital Management
Schonfeld Strategic Advisors
Geode Capital Management
Cresset Asset Management
Cantor Fitzgerald, L. P.
State Street Corporation
Two Sigma Investments
Northern Trust

View all funds holding Aardvark Therapeutics